Manufacturing

Jun 23, 2015
By BioPharm International Editors
apceth has completed a major GMP inspection for two medicinal products. The two cell and gene therapy products are now included in the company’s GMP manufacturing license according to §13 of the German Medicines Act (AMG).
Jun 16, 2015
The University of Pennsylvania announces that it will collaborate with WuXi AppTech to research and develop gene vectors derived from recombinant viruses.
Jun 16, 2015
The operational advantages of continuous manufacturing technology were showcased at BIO 2015.
Jun 14, 2015
BioPharm International eBooks
Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, cost of goods, and sustainability from the start.
Jun 14, 2015
BioPharm International eBooks
By BioPharm International Editors
Contract service providers share insights on biopharma market developments and the implications of biosimilar drug approvals.
Jun 10, 2015
By BioPharm International Editors
The exclusive manufacturing collaboration will establish production for adeno-associated virus gene-therapy treatments incorporating REGENXBIO’s NAV Technology.
Jun 07, 2015
By BioPharm International Editors
The Canadian Green Cross facility will produce intravenous immunoglobulin and albumin.
May 31, 2015
BioPharm International
Single-use and modular technologies plus continuous manufacturing are increasingly important to biopharma scale-up and tech transfer.
May 20, 2015
The House Energy and Commerce Committee gave unanimous approval to the landmark 21st Century Cures Act reform bill on May 21, 2015.
May 20, 2015
By BioPharm International Editors
Medicago's new production facility will make plant-based vaccines and therapeutics.